Physician
Howell, David
Howell, David was paid $1.27M by Medicaid between Jan 2018 and Mar 2023, across 30 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoHOWELL, DAVID
BROCKTON, MA 02301
BROCKTON, MA 02301
33aNPI1952379810assigned 03/08/2006
33bProvider typePediatrics Physician
28Total paid$1.27M
24GClaims34,698
24DCodes billed30
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#63 of 1,273
Median peer was paid$24K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,226 | $218K | |
| 2019 | 7,177 | $258K | |
| 2020 | 5,265 | $185K | |
| 2021 | 6,862 | $254K | |
| 2022 | 7,497 | $285K | |
| 2023 | 1,671 | $65K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 6,861 | 6,108 | $394K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 4,476 | 3,598 | $138K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 1,359 | 1,299 | $132K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.3% | 1,259 | 1,254 | $105K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.1% | 1,230 | 1,228 | $103K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.5% | 1,360 | 1,297 | $70K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.2% | 721 | 721 | $65K |
| 90461 | 3.1% | 918 | 916 | $39K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.0% | 4,237 | 4,231 | $38K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.8% | 449 | 444 | $35K |
| 99173 | 1.8% | 1,039 | 1,038 | $23K | |
| 96127 | 1.8% | 2,187 | 2,184 | $22K |
18 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 2,084 | $22K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 854 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 1,501 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 796 | $10K |
| 83655 | <1% | 489 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 161 | $6K |
| 92551 | <1% | 563 | $5K | |
| 85018 | <1% | 1,240 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 65 | $2K |
| 92552 | <1% | 69 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 72 | $1K |
| 81002 | <1% | 517 | $1K | |
| 80061 | Lipid panel | <1% | 82 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 13 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $427.28 |
| 99442 | <1% | 14 | $291.34 | |
| 87807 | <1% | 25 | $282.56 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 29 | $34.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.